Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisli Jenkins

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 7, 2023
Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosisBeatriz Guillen-Guio, Megan L Paynton, Richard J Allen, et al.
ERJ Open Research|February 20, 2024
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosisBeatriz Guillen-Guio, Megan L Paynton, Richard J Allen, et al.
American Journal of Respiratory and Critical Care Medicine|February 13, 2023
PCSK6 and Survival in Idiopathic Pulmonary FibrosisJustin M Oldham, Richard J Allen, Jose M Lorenzo-Salazar, et al.
The European Respiratory Journal|May 21, 2026
Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasetsDaniel Chin, Tamara Hernandez-Beeftink, Lauren Donoghue, et al.
The Lancet. Respiratory Medicine|October 10, 2021
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort studyRachael A Evans, Hamish McAuley, Ewen M Harrison, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasetsDaniel Chin, Tamara Hernandez-Beeftink, Lauren Donoghue, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Contribution of dominant and recessive model effects to the genetic architecture of Idiopathic Pulmonary FibrosisTamara Hernandez-Beeftink, Lauren J Donoghue, Abril Izquierdo, et al.
BMJ Open Respiratory Research|September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
Ebiomedicine|January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injuryIain Stewart, Joseph Jacob, Joanna C Porter, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Medrxiv : the Preprint Server for Health Sciences|August 7, 2023
Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosisBeatriz Guillen-Guio, Megan L Paynton, Richard J Allen, et al.
ERJ Open Research|February 20, 2024
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosisBeatriz Guillen-Guio, Megan L Paynton, Richard J Allen, et al.
American Journal of Respiratory and Critical Care Medicine|February 13, 2023
PCSK6 and Survival in Idiopathic Pulmonary FibrosisJustin M Oldham, Richard J Allen, Jose M Lorenzo-Salazar, et al.
The European Respiratory Journal|May 21, 2026
Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasetsDaniel Chin, Tamara Hernandez-Beeftink, Lauren Donoghue, et al.
The Lancet. Respiratory Medicine|October 10, 2021
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort studyRachael A Evans, Hamish McAuley, Ewen M Harrison, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasetsDaniel Chin, Tamara Hernandez-Beeftink, Lauren Donoghue, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Contribution of dominant and recessive model effects to the genetic architecture of Idiopathic Pulmonary FibrosisTamara Hernandez-Beeftink, Lauren J Donoghue, Abril Izquierdo, et al.
BMJ Open Respiratory Research|September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
Ebiomedicine|January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injuryIain Stewart, Joseph Jacob, Joanna C Porter, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
Pageof 21